Drug Delivery Technology Market

7500+ companies worldwide approach us every year for their revenue growth inititatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Drug Delivery Technology Market

Drug Delivery Technology Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal (Oral)), Patient Care Setting (Hospital, ASC) - Global Forecast to 2021

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 3871 Jan, 2017, by marketsandmarkets.com

[252 Pages Report] The global drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. This market is segmented based on route of administration, facility of use, and region.

Rising prevalence of chronic diseases, growth in biologics market, technological advancements and new product launches are some of the major factors driving the growth of the market. Drug delivery technologies improve the efficacy and safety of a drug by controlling the rate, time, and place of drug release in the body.

The drug delivery technology market is expected to witness significant growth in the coming years, due to the technological advancements and new product launches. With the rise in prevalence of diseases, it has become important for companies to manufacture smart and fast technologies, which offer effective treatments for diseases. A majority of companies operating in this market are involved in the research and development of drug delivery systems that can effectively cater to the needs of patients and enable effective delivery of drugs. This is expected to create growth opportunities for drug delivery companies in the market.

North America is projected to dominate the market in 2016, with the U.S. accounting for a major share. However, Asia is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to investments by major companies in the area of R&D activities. Also, this region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Apart from the comprehensive geographical analysis, product analysis, and market sizing; this report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change their strategic approach, R&D investments for innovations in products and technology, and levels of output in order to remain successful.

The drug delivery technology market is highly competitive market with various players. Prominent players in this market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).

Target Audience:

  • Drug Delivery Technology Manufacturers
  • Public and Private Physicians
  • Healthcare Institutions (Medical Data Centers)
  • Research & Clinical Laboratories
  • Distributors and Suppliers of Drug Delivery Technologies
  • Health Insurance Payers
  • Market Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the drug delivery technology market into the following segments and subsegments.

Drug Delivery Technology Market, by Route of Administration

  • Oral
  • Injectable
  • Topical
  • Ocular
  • Nasal
  • Pulmonary
  • Transmucosal
  • Implantable

Drug Delivery Technology Market, by Facility of Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care settings
  • Diagnostic Centers
  • Other Facilities of Use

Drug Delivery Technology Market, by Region 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia
    • China
    • India
    • Japan
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5).

Further Split of the RoW Drug Delivery Technology Market

Drug delivery technology market size and growth rate estimates of Latin America, Pacific, and the Middle East & Africa.

The drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic diseases, increasing demand for biologics, technological advancements, and new product launches are some of the major factors driving the growth of the market.

Furthermore, self-administration & home care and rising demand for biosimilars and generic drugs offer significant growth opportunities for player operating in the market. On the other hand, risk of needle-stick injuries and side effects of drugs may restraint the growth of the market.

The market is segmented based on route of administration, facility of use, and region. Based on route of administration, the market is segmented into oral, injectable, topical, nasal, ocular, pulmonary, implantable, and transmucosal. In 2016, the oral drug delivery segment is expected to account for the largest share of the market. This can be attributed to the factors such as, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe. No special training is required for the administration of these drugs, which is a major factor driving the growth of this market.

Based on facility of use, the market is segmented into the hospitals, ambulatory surgical centers/clinics, home care settings, diagnostic centers, and other facilities of use. In 2016, the hospitals segment is expected to account for the largest share of the market. This can be primarily attributed to factors such as the significant number of inpatient and outpatient visits in hospitals as compared to other end users and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of this patient pool. Additionally, the increasing need for drug administration due to the rising prevalence of chronic diseases, patient compliance, and safety are all factors contributing to the growth of the market for hospitals.

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While, North America is expected to dominate the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Prominent players in the drug delivery technology market include Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 Topical Drug Delivery: Market Overview
    4.2 Drug Delivery Technology Market, By Facility of Use
    4.3 Solid Oral Drug Delivery Technology Market, By Dosage Form
    4.4 Drug Delivery Technology Market, By Route of Administration
    4.5 Geographical Snapshot of the Drug Delivery Technology Market

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 Rising Prevalence of Chronic Diseases
           5.3.2 Growth in the Biologics Market
           5.3.3 Technological Advancement and New Product Launches
    5.4 Restraints
           5.4.1 Risk of Needlestick Injuries and Side Effects of Drugs
           5.4.2 Product Recalls
    5.5 Opportunities
           5.5.1 Self-Administration and Home Care
           5.5.2 Rising Demand for Biosimilars and Generic Drugs
                    5.5.2.1 Biosimilars
                    5.5.2.2 Generic Drugs
           5.5.3 Focus on Overcoming Unmet Medical Needs
           5.5.4 Emerging Markets
    5.6 Challenges
           5.6.1 Patent Expiry and Patent Cliff
           5.6.2 Pricing Pressure

6 Regulatory Scenario (Page No. - 52)
    6.1 Introduction
    6.2 Drug Approval in the U.S.
    6.3 Drug Approval in Europe

7 Drug Delivery Technology Market, By Route of Administration (Page No. - 55)
    7.1 Introduction
    7.2 Oral Drug Delivery
           7.2.1 Solid Oral Drugs
                    7.2.1.1 Tablets
                    7.2.1.2 Capsules
                    7.2.1.3 Powders
                    7.2.1.4 Pills
           7.2.2 Liquid Oral Drugs
                    7.2.2.1 Solutions
                    7.2.2.2 Syrups
           7.2.3 Semi-Solid Oral Drugs
                    7.2.3.1 Gels
                    7.2.3.2 Emulsions
                    7.2.3.3 Elixirs
    7.3 Pulmonary Drug Delivery
           7.3.1 Formulations
           7.3.2 Devices
                    7.3.2.1 Metered Dose Inhalers
                    7.3.2.2 Dry Powder Inhalers
                    7.3.2.3 Nebulizers
                               7.3.2.3.1 Jet Nebulizers
                               7.3.2.3.2 Ultrasonic Nebulizers
                               7.3.2.3.3 Soft Mist Nebulizers
    7.4 Injectable Drug Delivery
           7.4.1 Devices
                    7.4.1.1 Conventional Injection Devices
                               7.4.1.1.1 By Material
                               7.4.1.1.2 Glass
                               7.4.1.1.3 Plastic
                               7.4.1.1.4 By Product
                                             7.4.1.1.4.1 Fillable Syringes
                                             7.4.1.1.4.2 Prefilled Syringes
                               7.4.1.1.5 By Usability
                                             7.4.1.1.5.1 Reusable Syringes
                                             7.4.1.1.5.2 Disposable Syringes
                    7.4.1.2 Self-Injection Devices
                               7.4.1.2.1 Needle-Free Injectors
                               7.4.1.2.2 Autoinjectors
                               7.4.1.2.3 Pen Injectors
                               7.4.1.2.4 Wearable Injectors
                    7.4.1.3 Other Injector Devices
           7.4.2 Formulations
                    7.4.2.1 Conventional Drug Delivery
                    7.4.2.2 Novel Drug Delivery Formulations
                    7.4.2.3 Long-Acting Injection Formulations
    7.5 Ocular Drug Delivery
           7.5.1 Formulations
                    7.5.1.1 Liquid Formulations
                               7.5.1.1.1 Eye Drops
                               7.5.1.1.2 Liquid Sprays
                    7.5.1.2 Semi-Solid Formulations
                               7.5.1.2.1 Gels
                               7.5.1.2.2 Eye Ointments
           7.5.2 Ocular Devices
                    7.5.2.1 Drug-Coated Contact Lenses
                    7.5.2.2 Ocular Inserts
    7.6 Nasal Drug Delivery
           7.6.1 Nasal Drops
           7.6.2 Nasal Sprays
           7.6.3 Nasal Powders
           7.6.4 Nasal Gels
    7.7 Topical Drug Delivery
           7.7.1 Formulations
                    7.7.1.1 Liquid Topical Drug Delivery
                               7.7.1.1.1 Solutions
                               7.7.1.1.2 Suspensions
                    7.7.1.2 Semi-Solid Topical Drug Delivery
                               7.7.1.2.1 Creams
                               7.7.1.2.2 Gels
                               7.7.1.2.3 Ointments
                               7.7.1.2.4 Pastes
                               7.7.1.2.5 Lotions
                    7.7.1.3 Solid Topical Drug Delivery
                               7.7.1.3.1 Suppositories
                               7.7.1.3.2 Powders
           7.7.2 Devices (Transdermal Drug Delivery)
                    7.7.2.1 Transdermal Patches
                    7.7.2.2 Transdermal Gels
    7.8 Implantable Drug Delivery
           7.8.1 Active Implantable Drug Delivery
           7.8.2 Passive Implantable Drug Delivery
    7.9 Transmucosal Drug Delivery
           7.9.1 Oral Transmucosal Drug Delivery
                    7.9.1.1 Buccal Drug Delivery
                    7.9.1.2 Sublingual Drug Delivery
           7.9.2 Other Transmucosal Drug Delivery
                    7.9.2.1 Rectal Transmucosal Drug Delivery
                    7.9.2.2 Vaginal Transmucosal Drug Delivery

8 Drug Delivery Technology Market, By Facility of Use (Page No. - 134)
    8.1 Introduction
    8.2 Hospitals
    8.3 Ambulatory Surgical Centers/Clinics
    8.4 Home Care Settings
    8.5 Diagnostic Centers
    8.6 Other Facilities of Use

9 Drug Delivery Technology Market, By Region (Page No. - 141)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 U.K.
           9.3.4 Rest of Europe (RoE)
    9.4 Asia
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 170)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situations & Trends
             10.3.1 Product Launches & Approvals
             10.3.2 Partnerships, Agreements, and Collaborations
             10.3.3 Acquisitions, Mergers, and Joint Ventures
             10.3.4 Expansions

11 Company Profiles (Page No. - 178)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Introduction
     11.2 Johnson & Johnson Services, Inc.
     11.3 Novartis AG
     11.4 F. Hoffmann-La Roche Ltd.
     11.5 Pfizer, Inc.
     11.6 Bayer AG
     11.7 Antares Pharma, Inc.
     11.8 Becton, Dickinson and Company
     11.9 Glaxosmithkline PLC
     11.10 3M
     11.11 Merck & Co., Inc.
     11.12 Sanofi

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 227)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Other Recent Developments
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Available Customizations
     12.6 RT: Real-Time Market Intelligence
     12.7 Related Reports
     12.8 Author Details


List of Tables (170 Tables)

Table 1 Indicative List of Biologics Approved By Fda (2015 & 2016)
Table 2 Major Product Recalls in the Drug Delivery Technology Market, 2015
Table 3 Patent Expiry of Drugs, 2014–2015
Table 4 List of Regulatory Authorities, By Country
Table 5 Some of the Recently Approved Drugs By Fda
Table 6 Some of the Recently Approved Drugs in Europe
Table 7 Drug Delivery Technology Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 8 Oral Drug Delivery Technology Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 9 Oral Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Oral Drug Delivery Technology Market Size for Solid Drugs, By Dosage Form, 2014–2021 (USD Billion)
Table 11 Oral Drug Delivery Technology Market Size for Solid Drugs, By Region, 2014–2021 (USD Billion)
Table 12 Solid Oral Drugs Market Size for Tablets, By Region, 2014–2021 (USD Billion)
Table 13 Solid Oral Drugs Market Size for Capsules, By Region, 2014–2021 (USD Billion)
Table 14 Solid Oral Drugs Market Size for Powders, By Region, 2014–2021 (USD Billion)
Table 15 Solid Oral Drugs Market Size for Pills, By Region, 2014–2021 (USD Billion)
Table 16 Liquid Oral Drug Delivery Technology Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 17 Liquid Oral Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 18 Liquid Oral Drugs Market Size for Solutions, By Region, 2014–2021 (USD Billion)
Table 19 Liquid Oral Drugs Market Size for Syrups, By Region, 2014–2021 (USD Billion)
Table 20 Semi-Solid Oral Drug Delivery Technology Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 21 Semi-Solid Oral Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Semi-Solid Oral Drugs Market Size for Gels, By Region, 2014–2021 (USD Billion)
Table 23 Semi-Solid Oral Drugs Market Size for Emulsions, By Region, 2013–2020 (USD Billion)
Table 24 Semi-Solid Oral Drugs Market Size for Elixirs, By Region, 2014–2021 (USD Million)
Table 25 Pulmonary Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 26 Pulmonary Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 27 Pulmonary Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 28 Pulmonary Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 29 Pulmonary Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 30 Pulmonary Drug Delivery Devices Market Size for Metered Dose Inhalers, By Region, 2014–2021 (USD Billion)
Table 31 Pulmonary Drug Delivery Devices Market Size for Dry Powder Inhalers, By Region, 2013–2020 (USD Million)
Table 32 Pulmonary Drug Delivery Devices Market Size for Nebulizers, By Type, 2013–2020 (USD Million)
Table 33 Pulmonary Drug Delivery Devices Market Size for Nebulizers, By Region, 2014–2021 (USD Million)
Table 34 Jet Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 35 Ultrasonic Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 36 Soft Mist Nebulizers Market Size, By Region, 2014–2021 (USD Million)
Table 37 Injectable Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 38 Injectable Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 39 Conventional Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 40 Conventional Injection Devices Market Size, By Material, 2014–2021 (USD Billion)
Table 41 Conventional Glass Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 42 Conventional Plastic Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 43 Conventional Injection Devices Market Size, By Product, 2014–2021 (USD Billion)
Table 44 Conventional Fillable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 45 Conventional Prefilled Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 46 Conventional Injection Devices Market Size, By Usability, 2014–2021 (USD Billion)
Table 47 Conventional Reusable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 48 Conventional Disposable Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 49 Self-Injection Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 50 Self-Injection Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 51 Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Billion)
Table 52 Autoinjectors Market Size, By Region, 2014–2021 (USD Million)
Table 53 Commercially Available Key Pen Injectors
Table 54 Pen Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 55 Wearable Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 56 Other Injector Devices Market Size, By Region, 2014–2021 (USD Million)
Table 57 Injectable Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 58 Injectable Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 59 Conventional Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 60 Conventional Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 61 Novel Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 62 Novel Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 63 Long-Acting Injection Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 64 Ocular Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 65 Ocular Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 66 Ocular Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 67 Ocular Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 68 Liquid Ocular Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 69 Liquid Ocular Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 70 Commercially Available Eye Drops
Table 71 Eye Drops Market Size, By Region, 2014–2021 (USD Billion)
Table 72 Liquid Sprays Market Size, By Region, 2014–2021 (USD Billion)
Table 73 Semi-Solid Ocular Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 74 Semi-Solid Ocular Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 75 Ocular Gels Market Size, By Region, 2014–2021 (USD Million)
Table 76 Eye Ointments Market Size, By Region, 2014–2021 (USD Million)
Table 77 Ocular Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 78 Ocular Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 79 Drug-Coated Contact Lenses Market Size, By Region, 2014–2021 (USD Million)
Table 80 Ocular Inserts Market Size, By Region, 2014–2021 (USD Billion)
Table 81 Nasal Drug Delivery Technology Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 82 Nasal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 83 Nasal Drops Market Size, By Region, 2014–2021 (USD Billion)
Table 84 Nasal Sprays Market Size, By Region, 2014–2021 (USD Billion)
Table 85 Nasal Powders Market Size, By Region, 2014–2021 (USD Million)
Table 86 Nasal Gels Market Size, By Region, 2014–2021 (USD Million)
Table 87 Topical Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 88 Topical Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 89 Topical Drug Delivery Formulations Market Size, By Type, 2014–2021 (USD Billion)
Table 90 Topical Drug Delivery Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 91 Liquid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 92 Liquid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 93 Topical Solutions Market Size, By Region, 2014–2021 (USD Billion)
Table 94 Topical Suspensions Market Size, By Region, 2014–2021 (USD Billion)
Table 95 Semi-Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 96 Semi-Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 97 Topical Creams Market Size, By Region, 2014–2021 (USD Billion)
Table 98 Topical Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 99 Topical Ointments Market Size, By Region, 2014–2021 (USD Billion)
Table 100 Topical Pastes Market Size, By Region, 2014–2021 (USD Million)
Table 101 Topical Lotions Market Size, By Region, 2014–2021 (USD Billion)
Table 102 Solid Topical Formulations Market Size, By Dosage Form, 2014–2021 (USD Billion)
Table 103 Solid Topical Formulations Market Size, By Region, 2014–2021 (USD Billion)
Table 104 Topical Suppositories Market Size, By Region, 2014–2021 (USD Million)
Table 105 Topical Powders Market Size, By Region, 2014–2021 (USD Billion)
Table 106 Transdermal Drug Delivery Devices Market Size, By Type, 2014–2021 (USD Billion)
Table 107 Transdermal Drug Delivery Devices Market Size, By Region, 2014–2021 (USD Billion)
Table 108 Transdermal Patches Market Size, By Region, 2014–2021 (USD Billion)
Table 109 Transdermal Gels Market Size, By Region, 2014–2021 (USD Billion)
Table 110 Implantable Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 111 Implantable Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 112 Active Implantable Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 113 Passive Implantable Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 114 Transmucosal Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 115 Transmucosal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 116 Oral Transmucosal Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 117 Oral Transmucosal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 118 Buccal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 119 Sublingual Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Billion)
Table 120 Other Transmucosal Drug Delivery Technology Market Size, By Type, 2014–2021 (USD Billion)
Table 121 Other Transmucosal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 122 Rectal Transmucosal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 123 Vaginal Transmucosal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 124 Global Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 125 Global Market Size, By Region, 2014–2021 (USD Billion)
Table 126 Market Size for Hospitals, By Region, 2014–2021 (USD Billion)
Table 127 Market Size for Ambulatory Surgical Centers/Clinics, By Region, 2014–2021 (USD Billion)
Table 128 Market Size for Home Care Settings, By Region, 2014–2021 (USD Billion)
Table 129 Market Size for Diagnostic Centers, By Region, 2014–2021 (USD Billion)
Table 130 Market Size for Other Facilities of Use, By Region, 2014–2021 (USD Billion)
Table 131 Market Size, By Region, 2014-2021 (USD Billion)
Table 132 North America: Market Size, By Country, 2014-2021 (USD Billion)
Table 133 North America: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 134 North America: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 135 U.S.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 136 U.S.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 137 Canada: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 138 Canada: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 139 Europe: Market Size, By Country, 2014-2021 (USD Billion)
Table 140 Europe: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 141 Europe: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 142 Germany: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 143 Germany: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 144 France: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 145 France: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 146 U.K.: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 147 U.K.: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 148 RoE: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 149 RoE: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 150 Asia: Market Size, By Country, 2014-2021 (USD Billion)
Table 151 Asia: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 152 Asia: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 153 Japan: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 154 Japan: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 155 China: Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 156 China: Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 157 India: Drug Delivery Technology Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 158 India: Drug Delivery Technology Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 159 RoA: Drug Delivery Technology Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 160 RoA: Drug Delivery Technology Market Size, By End User, 2014–2021 (USD Billion)
Table 161 RoW: Drug Delivery Technology Market Size, By Route of Administration, 2014–2021 (USD Billion)
Table 162 RoW: Drug Delivery Technology Market Size, By Facility of Use, 2014–2021 (USD Billion)
Table 163 Product Launches & Approvals, 2014–2016
Table 164 Partnerships, Agreements, and Collaborations, 2014–2016
Table 165 Acquisitions, Mergers, and Joint Ventures, 2014–2016
Table 166 Expansions, 2014–2016
Table 167 Exchange Rates (Utilized for Conversion of CHF to USD)
Table 168 Exchange Rate (Utilized for Conversion of EUR to USD)
Table 169 Exchange Rate (Utilized for Conversion of GBP to USD)
Table 170 Exchange Rate (Utilized for Conversion of EUR to USD)


List of Figures (37 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Drug Delivery Technology Market, By Route of Administration (2016)
Figure 7 Oral Drug Delivery Technology Market Size for Solid Drugs, By Dosage Form, 2016 vs 2021 (USD Billion)
Figure 8 Drug Delivery Technology Market Size, By Facility of Use, 2016 vs 2021 (USD Billion)
Figure 9 Drug Delivery Technology Market, By Region,
Figure 10 Ease of Use, Rising Prevalence of Chronic Diseases are Driving Market Growth
Figure 11 Hospitals Segment to Hold Largest Market Share From 2016 to 2021
Figure 12 Tablets Segment to Account for the Largest Share in 2016
Figure 13 Oral Drug Delivery to Hold Largest Share in the Market in 2016
Figure 14 China to Witness Highest Growth During the Forecast Period
Figure 15 Drug Delivery Technology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Topical Drug Delivery to Witness Highest Growth During the Forecast Period
Figure 17 The Hospitals Segment is Expected to Command the Largest Share of the Drug Delivery Technology Market in 2016
Figure 18 North America: Drug Delivery Technology Market Snapshot
Figure 19 Europe: Drug Delivery Technology Market Snapshot
Figure 20 Asia: Drug Delivery Technology Market Snapshot
Figure 21 RoW: Drug Delivery Technology Market Snapshot
Figure 22 Product Launches & Approvals: Key Growth Strategy Adopted By Players in the Drug Delivery Technology Market (2014–2016)
Figure 23 Global Drug Delivery Technology Market Share, By Key Player (2015)
Figure 24 Market Evolution Framework: Product Launches & Approvals are Fueling Market Growth
Figure 25 Battle for Market Share: Product Launches & Approvals is the Key Growth Strategy Adopted By Leading Market Players
Figure 26 Geographic Revenue Mix for the Top 5 Players
Figure 27 Johnson & Johnson Services, Inc.: Company Snapshot (2015)
Figure 28 Novartis AG: Company Snapshot (2015)
Figure 29 F. Hoffmann-La Roche Ltd.: Company Snapshot (2015)
Figure 30 Pfizer, Inc.: Company Snapshot (2015)
Figure 31 Bayer AG: Company Snapshot (2015)
Figure 32 Antares Pharma, Inc.: Company Snapshot (2015)
Figure 33 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 34 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 35 3M: Company Snapshot (2015)
Figure 36 Merck & Co., Inc.: Company Snapshot (2015)
Figure 37 Sanofi: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3871
Published ON
Jan, 2017
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Drug Delivery Technology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved